scispace - formally typeset
Open AccessJournal ArticleDOI

Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread

Reads0
Chats0
TLDR
A parabiosis model is used that demonstrates preferential hematogenous metastasis of ovarian cancer to the omentum and reveals that the ErbB3-neuregulin 1 (NRG1) axis is a dominant pathway responsible for hematogeneous omental metastasis.
About
This article is published in Cancer Cell.The article was published on 2014-07-14 and is currently open access. It has received 256 citations till now. The article focuses on the topics: Metastasis & Ovarian cancer.

read more

Citations
More filters
Journal ArticleDOI

Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer

TL;DR: This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015 and aims to reduce incidence and improve outcomes for women with this disease.
Journal ArticleDOI

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

TL;DR: A view of how the somatic genome drives the cancer proteome and associations between protein and post-translational modification levels and clinical outcomes in HGSC is provided.
Journal ArticleDOI

Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells

TL;DR: How circulate tumour cell (CTC) analysis at single-cell resolution provides unique insights into tumour heterogeneity that are not revealed by analysis of circulating tumour DNA (ctDNA) derived from liquid biopsies is discussed.
Journal ArticleDOI

Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer

TL;DR: It is determined that TAMs promote spheroid formation and tumor growth at early stages of transcoelomic metastasis in an established mouse model for epithelial ovarian cancer.
References
More filters
Journal ArticleDOI

Integrated genomic analyses of ovarian carcinoma

Debra A. Bell, +285 more
- 30 Jun 2011 - 
TL;DR: It is reported that high-grade serous ovarian cancer is characterized by TP53 mutations in almost all tumours (96%); low prevalence but statistically recurrent somatic mutations in nine further genes including NF1, BRCA1,BRCA2, RB1 and CDK12; 113 significant focal DNA copy number aberrations; and promoter methylation events involving 168 genes.

Integrated genomic analyses of ovarian carcinoma

Daphne W. Bell, +261 more
TL;DR: The Cancer Genome Atlas project has analyzed messenger RNA expression, microRNA expression, promoter methylation and DNA copy number in 489 high-grade serous ovarian adenocarcinomas and the DNA sequences of exons from coding genes in 316 of these tumours as mentioned in this paper.
Journal ArticleDOI

Carcinoma of the Ovary.

TL;DR: The final histologic findings after surgery (and cytologic ones when available) are to be considered in the staging, which may be modified by histopathologic as well as clinical or radiological evaluation.
Related Papers (5)

Integrated genomic analyses of ovarian carcinoma

Debra A. Bell, +285 more
- 30 Jun 2011 -